Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Rifampicin FDCs in Healthy Volunteers
NCT02953847Phase 1Completed
- Sponsor
- University of Cape Town
- Start
- Nov 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of rifampicin in Tuberculosis (TB) (6 arms), sponsored by University of Cape Town. Primary endpoint: Maximum Observed Plasma Concentration at 1 year. Started Nov 2016; status: completed.
02
Drugs
rifampicin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02953847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953847.